{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T02:22:16Z","timestamp":1794968536576,"version":"4.9.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T00:00:00Z","timestamp":1584316800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T00:00:00Z","timestamp":1584316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["85134"],"award-info":[{"award-number":["85134"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Dyslipidemia may be defined as increased levels of serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), or a decreased serum high-density lipoprotein cholesterol (HDL-C) concentration. Dyslipidemia is an established risk factor for cardiovascular disease (CVD). We aimed to investigate the association of dyslipidemia and CVD events among a population sample from Mashhad, in northeastern Iran.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and methods<\/jats:title>\n                    <jats:p>This prospective cohort study comprised a population of 8698 men and women aged 35\u201365\u2009years who were recruited from the Mashhad Stroke and Heart Atherosclerotic Disorder (MASHAD) study. Socioeconomic and demographic status, anthropometric parameters, laboratory evaluations, lifestyle factors, and medical history were gathered through a comprehensive questionnaire and laboratory and clinical assessment for all participants. Cox regression model and 95% confidence interval (CI) were used to evaluate the association of dyslipidemia and its components with CVD incidence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      After 6\u2009years of follow-up, 233 cases of CVD (including 119 cases of unstable angina [US], 74 cases of stable angina [SA], and 40 cases of myocardial infarction [MI]) were identified in the study population. Unadjusted baseline serum LDL-C, TC, and TG levels were positively associated with the risk of total CVD events among the entire population (HR: 1.54, 95% CI: 1.19\u20132;\n                      <jats:italic>P<\/jats:italic>\n                      -value&lt;\u20090.01; HR: 1.53; 95% CI: 1.18\u20131.98;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01; HR: 1.57; 95% CI: 1.27\u20132.03; P\u2009&lt;\u20090.01, respectively). However, after adjusting for confounding factors (age, body mass index [BMI], family history of CVD, smoking status [non-smoker, ex-smoker and current smoker], lipid lowering drug treatment, anti-hypertensive drug treatment, hypertension, healthy eating index [HEI], total energy intake, and presence of diabetes mellitus), a significant direct association only remained between TC and MI risk in men (HR: 2.71; 95%CI: 1.12\u20136.57;\n                      <jats:italic>P<\/jats:italic>\n                      -value&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In the present study, TC baseline level was significantly associated with the risk of MI among men.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12944-020-01204-y","type":"journal-article","created":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T08:05:01Z","timestamp":1584345901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":308,"title":["Dyslipidemia and cardiovascular disease risk among the MASHAD study population"],"prefix":"10.1186","volume":"19","author":[{"given":"Mahshad","family":"Hedayatnia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Asadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Zare-Feyzabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdiyeh","family":"Yaghooti-Khorasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamideh","family":"Ghazizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshanak","family":"Ghaffarian-Zirak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolfazl","family":"Nosrati-Tirkani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Mohammadi-Bajgiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohadese","family":"Rohban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Sadabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid-Reza","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzieh","family":"Ghalandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Seddigh","family":"Ghaffari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asa","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnaz","family":"Pouresmaeili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad-Reza","family":"Besharatlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Moohebati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon A.","family":"Ferns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habibollah","family":"Esmaily","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1081-6754","authenticated-orcid":false,"given":"Majid","family":"Ghayour-Mobarhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,16]]},"reference":[{"issue":"6","key":"1204_CR1","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/sj.ijo.0801224","volume":"24","author":"G Guzzaloni","year":"2000","unstructured":"Guzzaloni G, Grugni G, Minocci A, Moro D, Morabito F. Liver steatosis in juvenile obesity: correlations with lipid profile, hepatic biochemical parameters and glycemic and insulinemic responses to an oral glucose tolerance test. Int J Obes. 2000;24(6):772.","journal-title":"Int J Obes"},{"issue":"4","key":"1204_CR2","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.3390\/nu5041218","volume":"5","author":"B Klop","year":"2013","unstructured":"Klop B, Elte JWF, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients. 2013;5(4):1218\u201340.","journal-title":"Nutrients"},{"key":"1204_CR3","first-page":"240","volume":"29","author":"S Niroumand","year":"2015","unstructured":"Niroumand S, Khajedaluee M, Khadem-Rezaiyan M, Abrishami M, Juya M, Khodaee G, et al. Atherogenic index of plasma (AIP): a marker of cardiovascular disease. Med J Islam Repub Iran. 2015;29:240.","journal-title":"Med J Islam Repub Iran"},{"issue":"9","key":"1204_CR4","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/oby.2000.79","volume":"8","author":"CD Brown","year":"2000","unstructured":"Brown CD, Higgins M, Donato KA, Rohde FC, Garrison R, Obarzanek E, et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res. 2000;8(9):605\u201319.","journal-title":"Obes Res"},{"issue":"5","key":"1204_CR5","doi-asserted-by":"publisher","first-page":"e96808","DOI":"10.1371\/journal.pone.0096808","volume":"9","author":"SR Joshi","year":"2014","unstructured":"Joshi SR, Anjana RM, Deepa M, Pradeepa R, Bhansali A, Dhandania VK, et al. Prevalence of dyslipidemia in urban and rural India: the ICMR\u2013INDIAB study. PLoS One. 2014;9(5):e96808.","journal-title":"PLoS One"},{"issue":"12","key":"1204_CR6","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1001\/archinte.164.12.1313","volume":"164","author":"JG O\u2019meara","year":"2004","unstructured":"O\u2019meara JG, Kardia SL, Armon JJ, Brown CA, Boerwinkle E, Turner ST. Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. Arch Intern Med. 2004;164(12):1313\u20138.","journal-title":"Arch Intern Med"},{"issue":"4","key":"1204_CR7","first-page":"373","volume":"5","author":"O Tabatabaei-Malazy","year":"2014","unstructured":"Tabatabaei-Malazy O, Qorbani M, Samavat T, Sharifi F, Larijani B, Fakhrzadeh H. Prevalence of dyslipidemia in Iran: a systematic review and meta-analysis study. Int J Prev Med. 2014;5(4):373.","journal-title":"Int J Prev Med"},{"issue":"8","key":"1204_CR8","doi-asserted-by":"publisher","first-page":"e22579","DOI":"10.1002\/jcla.22579","volume":"32","author":"S Darroudi","year":"2018","unstructured":"Darroudi S, Saberi-Karimian M, Tayefi M, Arekhi S, Motamedzadeh Torghabeh A, Seyedzadeh Sani SMR, et al. Prevalence of combined and noncombined dyslipidemia in an Iranian population. J Clin Lab Anal. 2018;32(8):e22579.","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"1204_CR9","first-page":"506","volume":"46","author":"M Sadeghi","year":"2017","unstructured":"Sadeghi M, Haghdoost AA, Bahrampour A, Dehghani M. Modeling the burden of cardiovascular diseases in Iran from 2005 to 2025: the impact of demographic changes. Iran J Public Health. 2017;46(4):506.","journal-title":"Iran J Public Health"},{"issue":"11","key":"1204_CR10","doi-asserted-by":"publisher","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","volume":"3","author":"CD Mathers","year":"2006","unstructured":"Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442.","journal-title":"PLoS Med"},{"key":"1204_CR11","volume-title":"Global atlas on cardiovascular disease prevention and control","author":"S Mendis","year":"2011","unstructured":"Mendis S, Puska P, Norrving B, Organization WH. Global atlas on cardiovascular disease prevention and control. Geneva: World Health Organization; 2011."},{"issue":"2","key":"1204_CR12","doi-asserted-by":"publisher","first-page":"443S","DOI":"10.1093\/ajcn\/83.2.443S","volume":"83","author":"JM Ordovas","year":"2006","unstructured":"Ordovas JM. Genetic interactions with diet influence the risk of cardiovascular disease. Am J Clin Nutr. 2006;83(2):443S\u20136S.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"1204_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-511X-6-1","volume":"6","author":"DM Martirosyan","year":"2007","unstructured":"Martirosyan DM, Miroshnichenko LA, Kulakova SN, Pogojeva AV, Zoloedov VI. Amaranth oil application for coronary heart disease and hypertension. Lipids Health Dis. 2007;6(1):1.","journal-title":"Lipids Health Dis"},{"issue":"7121","key":"1204_CR14","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/nature05488","volume":"444","author":"J-P Despr\u00e9s","year":"2006","unstructured":"Despr\u00e9s J-P, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881.","journal-title":"Nature"},{"key":"1204_CR15","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.trsl.2015.10.001","volume":"168","author":"P Tveden-Nyborg","year":"2016","unstructured":"Tveden-Nyborg P, Birck MM, Ipsen DH, Thiessen T, de Bie FL, Lindblad MM, et al. Diet-induced dyslipidemia leads to nonalcoholic fatty liver disease and oxidative stress in Guinea pigs. Transl Res. 2016;168:146\u201360.","journal-title":"Transl Res"},{"issue":"4","key":"1204_CR16","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/01.hjr.0000216552.81882.ca","volume":"13","author":"F Hadaegh","year":"2006","unstructured":"Hadaegh F, Harati H, Ghanbarian A, Azizi F. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran lipid and glucose study. Eur J Cardiovasc Prev Rehabil. 2006;13(4):571\u20137.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"9","key":"1204_CR17","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1161\/01.ATV.0000084638.14534.0A","volume":"23","author":"SD Proctor","year":"2003","unstructured":"Proctor SD, Mamo JC. Intimal retention of cholesterol derived from apolipoprotein B100\u2013and apolipoprotein B48\u2013containing lipoproteins in carotid arteries of Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb Vasc Biol. 2003;23(9):1595\u2013600.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"1204_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/00041433-200210000-00001","volume":"13","author":"SD Proctor","year":"2002","unstructured":"Proctor SD, Vine DF, Mamo JC. Arterial retention of apolipoprotein B48-and B100-containing lipoproteins in atherogenesis. Curr Opin Lipidol. 2002;13(5):461\u201370.","journal-title":"Curr Opin Lipidol"},{"issue":"11","key":"1204_CR19","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1161\/01.ATV.0000143859.75035.5a","volume":"24","author":"SD Proctor","year":"2004","unstructured":"Proctor SD, Vine DF, Mamo JC. Arterial permeability and efflux of apolipoprotein B\u2013containing lipoproteins assessed by in situ perfusion and three-dimensional quantitative confocal microscopy. Arterioscler Thromb Vasc Biol. 2004;24(11):2162\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"1204_CR20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrcardio.2017.31","volume":"14","author":"\u017d Reiner","year":"2017","unstructured":"Reiner \u017d. Hypertriglyceridaemia and risk of coronary artery disease. Nat Rev Cardiol. 2017;14(7):401.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"1204_CR21","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","volume":"118","author":"BG Nordestgaard","year":"2016","unstructured":"Nordestgaard BG. Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology. Circ Res. 2016;118(4):547\u201363.","journal-title":"Circ Res"},{"issue":"3","key":"1204_CR22","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1152\/physrev.00019.2011","volume":"92","author":"NA Abumrad","year":"2012","unstructured":"Abumrad NA, Davidson NO. Role of the gut in lipid homeostasis. Physiol Rev. 2012;92(3):1061\u201385.","journal-title":"Physiol Rev"},{"issue":"4","key":"1204_CR23","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","volume":"8","author":"M Navab","year":"2011","unstructured":"Navab M, Reddy ST, Van Lenten BJ, Fogelman AM. HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat Rev Cardiol. 2011;8(4):222.","journal-title":"Nat Rev Cardiol"},{"issue":"18","key":"1204_CR24","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1161\/01.CIR.0000146339.57154.9B","volume":"110","author":"I Shai","year":"2004","unstructured":"Shai I, Rimm EB, Hankinson SE, Curhan G, Manson JE, Rifai N, et al. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines. Circulation. 2004;110(18):2824\u201330.","journal-title":"Circulation"},{"issue":"6","key":"1204_CR25","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/S0002-8703(03)00516-7","volume":"146","author":"TP Bersot","year":"2003","unstructured":"Bersot TP, P\u00e9pin GM, Mahley RW. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol. Am Heart J. 2003;146(6):1052\u20139.","journal-title":"Am Heart J"},{"issue":"4","key":"1204_CR26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/00041433-200308000-00005","volume":"14","author":"V Bittner","year":"2003","unstructured":"Bittner V. Non-high-density lipoprotein cholesterol and cardiovascular disease. Curr Opin Lipidol. 2003;14(4):367\u201371.","journal-title":"Curr Opin Lipidol"},{"key":"1204_CR27","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.ijcard.2016.06.091","volume":"220","author":"SP Glasser","year":"2016","unstructured":"Glasser SP, Mosher A, Howard G, Banach M. What is the association of lipid levels and incident stroke? Int J Cardiol. 2016;220:890\u20134.","journal-title":"Int J Cardiol"},{"key":"1204_CR28","volume-title":"The Minnesota code manual of electrocardiographic findings: Springer Science & Business Media","author":"RJ Prineas","year":"2009","unstructured":"Prineas RJ, Crow RS, Zhang Z-M. The Minnesota code manual of electrocardiographic findings: Springer Science & Business Media; 2009."},{"issue":"9","key":"1204_CR29","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.2105\/AJPH.84.9.1383","volume":"84","author":"RV Luepker","year":"1994","unstructured":"Luepker RV, Murray DM, Jacobs DR Jr, Mittelmark MB, Bracht N, Carlaw R, et al. Community education for cardiovascular disease prevention: risk factor changes in the Minnesota heart health program. Am J Public Health. 1994;84(9):1383\u201393.","journal-title":"Am J Public Health"},{"key":"1204_CR30","first-page":"25","volume":"1","author":"K Norton","year":"1996","unstructured":"Norton K, Whittingham N, Carter L, Kerr D, Gore C, Marfell-Jones M. Measurement techniques in anthropometry. Anthropometrica. 1996;1:25\u201375.","journal-title":"Anthropometrica"},{"issue":"14","key":"1204_CR31","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1001\/jama.288.14.1728","volume":"288","author":"CL Ogden","year":"2002","unstructured":"Ogden CL, Flegal KM, Carroll MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA. 2002;288(14):1728\u201332.","journal-title":"JAMA"},{"issue":"2","key":"1204_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/07448480309595728","volume":"52","author":"TT-K Huang","year":"2003","unstructured":"Huang TT-K, Harris KJ, Lee RE, Nazir N, Born W, Kaur H. Assessing overweight, obesity, diet, and physical activity in college students. J Am Coll Health. 2003;52(2):83\u20136.","journal-title":"J Am Coll Health"},{"issue":"19","key":"1204_CR33","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Expert Panel on Detection E","year":"2001","unstructured":"Expert Panel on Detection E. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486.","journal-title":"JAMA"},{"key":"1204_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.gene.2016.10.034","volume":"598","author":"H Ghazizadeh","year":"2017","unstructured":"Ghazizadeh H, Fazilati M, Pasdar A, Avan A, Tayefi M, Ghasemi F, et al. Association of a vascular endothelial growth factor genetic variant with serum VEGF level in subjects with metabolic syndrome. Gene. 2017;598:27\u201331.","journal-title":"Gene"},{"key":"1204_CR35","volume-title":"Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO\/IDF consultation","author":"Organization WH","year":"2006","unstructured":"Organization WH. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO\/IDF consultation. 2006."},{"issue":"11","key":"1204_CR36","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1111\/j.1751-7176.2009.00179.x","volume":"11","author":"TD Giles","year":"2009","unstructured":"Giles TD, Materson BJ, Cohn JN, Kostis JB. Definition and classification of hypertension: an update. J Clin Hyper. 2009;11(11):611\u20134.","journal-title":"J Clin Hyper"},{"key":"1204_CR37","unstructured":"James WPT, Schofield EC. Human energy requirements. A manual for planners and nutritionists. Oxford: Oxford University Press; 1990. ISBN: 0192618911."},{"issue":"3","key":"1204_CR38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/biof.1424","volume":"44","author":"M Ahmadnezhad","year":"2018","unstructured":"Ahmadnezhad M, Arefhosseini SR, Parizadeh MR, Tavallaie S, Tayefi M, Darroudi S, et al. Association between serum uric acid, high sensitive C-reactive protein and pro-oxidant-antioxidant balance in patients with metabolic syndrome. BioFactors. 2018;44(3):263\u201371.","journal-title":"BioFactors"},{"key":"1204_CR39","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/jhn.12669","volume":"32","author":"Z Asadi","year":"2019","unstructured":"Asadi Z, Shafiee M, Sadabadi F, Heidari-Bakavoli A, Moohebati M, Khorrami M, et al. Association of dietary patterns and risk of cardiovascular disease events in the MASHAD cohort study. J Hum Nutr Diet. 2019;32:789\u2013801.","journal-title":"J Hum Nutr Diet"},{"issue":"1","key":"1204_CR40","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.dsx.2018.11.059","volume":"13","author":"Z Asadi","year":"2019","unstructured":"Asadi Z, Shafiee M, Sadabadi F, Saberi-Karimian M, Darroudi S, Tayefi M, et al. Association of dietary patterns and the risk of metabolic syndrome among Iranian population: a cross-sectional study. Diabetes Metab Syndr. 2019;13(1):858\u201365.","journal-title":"Diabetes Metab Syndr"},{"key":"1204_CR41","first-page":"49","volume":"3","author":"M Ahmadnezhad","year":"2017","unstructured":"Ahmadnezhad M, Asadi Z, Miri HH, Ferns GA, Ghayour-Mobarhan M, Ebrahimi-Mamaghani M. Validation of a short semi-quantitative food frequency questionnaire for adults: a pilot study. J Nutr Sci Diet. 2017;3:49\u201355.","journal-title":"J Nutr Sci Diet"},{"issue":"4","key":"1204_CR42","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jand.2012.12.016","volume":"113","author":"PM Guenther","year":"2013","unstructured":"Guenther PM, Casavale KO, Reedy J, Kirkpatrick SI, Hiza HA, Kuczynski KJ, et al. Update of the healthy eating index: HEI-2010. J Acad Nutr Diet. 2013;113(4):569\u201380.","journal-title":"J Acad Nutr Diet"},{"issue":"9","key":"1204_CR43","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.jada.2004.06.020","volume":"104","author":"D Feskanich","year":"2004","unstructured":"Feskanich D, Rockett HR, Colditz GA. Modifying the healthy eating index to assess diet quality in children and adolescents. J Am Diet Assoc. 2004;104(9):1375\u201383.","journal-title":"J Am Diet Assoc"},{"key":"1204_CR44","first-page":"110","volume":"63","author":"M T\u00e4ger","year":"2016","unstructured":"T\u00e4ger M, Peltner J, Thiele S. Evaluation of diet quality by means of the healthy eating index and its modified variants. Ern\u00e4hrungs Umschau. 2016;63:110\u20138.","journal-title":"Ern\u00e4hrungs Umschau"},{"issue":"1","key":"1204_CR45","first-page":"1","volume":"2","author":"S Khakpouri","year":"2019","unstructured":"Khakpouri S, Safari M, Ghazizadeh H, Parizadeh SMR, Nematy M, Tayefi M, et al. The relationship between the healthy eating index and an alternate healthy eating index with the risk factors for cardiovascular disease in a population from northeastern Iran. Transl Metabol Syn Res. 2019;2(1):1\u20136.","journal-title":"Transl Metabol Syn Res"},{"issue":"9","key":"1204_CR46","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s11886-019-1175-z","volume":"21","author":"AN Berman","year":"2019","unstructured":"Berman AN, Blankstein R. Optimizing dyslipidemia Management for the Prevention of cardiovascular disease: a focus on risk assessment and therapeutic options. Curr Cardiol Rep. 2019;21(9):110.","journal-title":"Curr Cardiol Rep"},{"issue":"24","key":"1204_CR47","doi-asserted-by":"publisher","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","volume":"73","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, et al. 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2019;73(24):e285\u2013350.","journal-title":"J Am Coll Cardiol"},{"issue":"39","key":"1204_CR48","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","volume":"37","author":"AL Catapano","year":"2016","unstructured":"Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, et al. 2016 ESC\/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2016;37(39):2999\u20133058.","journal-title":"Eur Heart J"},{"issue":"9943","key":"1204_CR49","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0140-6736(14)61009-6","volume":"384","author":"PM Ridker","year":"2014","unstructured":"Ridker PM. LDL cholesterol: controversies and future therapeutic directions. Lancet. 2014;384(9943):607\u201317.","journal-title":"Lancet"},{"issue":"18","key":"1204_CR50","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","volume":"376","author":"MS Sabatine","year":"2017","unstructured":"Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017;376(18):1713\u201322.","journal-title":"N Engl J Med"},{"issue":"22","key":"1204_CR51","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","volume":"379","author":"GG Schwartz","year":"2018","unstructured":"Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, et al. Alirocumab and cardiovascular outcomes after acute coronary syndrome. N Engl J Med. 2018;379(22):2097\u2013107.","journal-title":"N Engl J Med"},{"issue":"1","key":"1204_CR52","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ajhg.2007.11.001","volume":"82","author":"C Wallace","year":"2008","unstructured":"Wallace C, Newhouse SJ, Braund P, Zhang F, Tobin M, Falchi M, et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet. 2008;82(1):139\u201349.","journal-title":"Am J Hum Genet"},{"issue":"18","key":"1204_CR53","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","volume":"97","author":"PW Wilson","year":"1998","unstructured":"Wilson PW, D\u2019Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837\u201347.","journal-title":"Circulation"},{"issue":"2","key":"1204_CR54","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1161\/ATVBAHA.117.310269","volume":"38","author":"A Varbo","year":"2018","unstructured":"Varbo A, Nordestgaard BG. Nonfasting triglycerides, low-density lipoprotein cholesterol, and heart failure risk: two cohort studies of 113 554 individuals. Arterioscler Thromb Vasc Biol. 2018;38(2):464\u201372.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"1204_CR55","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.jacl.2007.10.001","volume":"1","author":"WC Cromwell","year":"2007","unstructured":"Cromwell WC, Otvos JD, Keyes MJ, Pencina MJ, Sullivan L, Vasan RS, et al. LDL particle number and risk of future cardiovascular disease in the Framingham offspring study\u2014implications for LDL management. J Clin Lipidol. 2007;1(6):583\u201392.","journal-title":"J Clin Lipidol"},{"issue":"6","key":"1204_CR56","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.amjcard.2016.06.048","volume":"118","author":"MJ van den Berg","year":"2016","unstructured":"van den Berg MJ, van der Graaf Y, de Borst GJ, Kappelle LJ, Nathoe HM, Visseren FL, et al. Low-density lipoprotein cholesterol, non\u2013high-density lipoprotein cholesterol, triglycerides, and Apolipoprotein B and cardiovascular risk in patients with manifest arterial disease. Am J Cardiol. 2016;118(6):804\u201310.","journal-title":"Am J Cardiol"},{"issue":"18","key":"1204_CR57","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1001\/jama.291.18.2204","volume":"291","author":"DM Lloyd-Jones","year":"2004","unstructured":"Lloyd-Jones DM, Nam B-H, D\u2019Agostino RB Sr, Levy D, Murabito JM, Wang TJ, et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA. 2004;291(18):2204\u201311.","journal-title":"JAMA"},{"issue":"9943","key":"1204_CR58","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S0140-6736(14)61177-6","volume":"384","author":"BG Nordestgaard","year":"2014","unstructured":"Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet. 2014;384(9943):626\u201335.","journal-title":"Lancet"},{"issue":"11","key":"1204_CR59","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","volume":"32","author":"MJ Chapman","year":"2011","unstructured":"Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Bor\u00e9n J, Catapano AL, et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J. 2011;32(11):1345\u201361.","journal-title":"Eur Heart J"},{"issue":"2","key":"1204_CR60","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.archger.2010.03.022","volume":"52","author":"EV de Freitas","year":"2011","unstructured":"de Freitas EV, Brand\u00e3o AA, Pozzan R, Magalh\u00e3es ME, Fonseca F, Pizzi O, et al. Importance of high-density lipoprotein-cholesterol (HDL-C) levels to the incidence of cardiovascular disease (CVD) in the elderly. Arch Gerontol Geriatr. 2011;52(2):217\u201322.","journal-title":"Arch Gerontol Geriatr"},{"key":"1204_CR61","doi-asserted-by":"publisher","first-page":"b92","DOI":"10.1136\/bmj.b92","volume":"338","author":"M Briel","year":"2009","unstructured":"Briel M, Ferreira-Gonzalez I, You JJ, Karanicolas PJ, Akl EA, Wu P, et al. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. BMJ. 2009;338:b92.","journal-title":"BMJ"},{"issue":"12","key":"1204_CR62","doi-asserted-by":"publisher","first-page":"e007402","DOI":"10.1161\/JAHA.117.007402","volume":"6","author":"PR Lawler","year":"2017","unstructured":"Lawler PR, Akinkuolie AO, Harada P, Glynn RJ, Chasman DI, Ridker PM, et al. Residual risk of atherosclerotic cardiovascular events in relation to reductions in very-low-density lipoproteins. J Am Heart Assoc. 2017;6(12):e007402.","journal-title":"J Am Heart Assoc"},{"issue":"46","key":"1204_CR63","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.1093\/eurheartj\/eht163","volume":"34","author":"E Angeloni","year":"2013","unstructured":"Angeloni E, Paneni F, Landmesser U, Benedetto U, Melina G, L\u00fcscher TF, et al. Lack of protective role of HDL-C in patients with coronary artery disease undergoing elective coronary artery bypass grafting. Eur Heart J. 2013;34(46):3557\u201362.","journal-title":"Eur Heart J"},{"issue":"6","key":"1204_CR64","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jacc.2007.09.060","volume":"51","author":"WA van der Steeg","year":"2008","unstructured":"van der Steeg WA, Holme I, Boekholdt SM, Larsen ML, Lindahl C, Stroes ES, et al. High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein AI: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies. J Am Coll Cardiol. 2008;51(6):634\u201342.","journal-title":"J Am Coll Cardiol"},{"issue":"9943","key":"1204_CR65","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S0140-6736(14)61217-4","volume":"384","author":"DJ Rader","year":"2014","unstructured":"Rader DJ, Hovingh GK. HDL and cardiovascular disease. Lancet. 2014;384(9943):618\u201325.","journal-title":"Lancet"},{"issue":"21","key":"1204_CR66","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1016\/j.jacc.2016.03.538","volume":"67","author":"P Mody","year":"2016","unstructured":"Mody P, Joshi PH, Khera A, Ayers CR, Rohatgi A. Beyond coronary calcification, family history, and C-reactive protein: cholesterol efflux capacity and cardiovascular risk prediction. J Am Coll Cardiol. 2016;67(21):2480\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"1204_CR67","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","volume":"371","author":"A Rohatgi","year":"2014","unstructured":"Rohatgi A, Khera A, Berry JD, Givens EG, Ayers CR, Wedin KE, et al. HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med. 2014;371(25):2383\u201393.","journal-title":"N Engl J Med"},{"issue":"10155","key":"1204_CR68","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/S0140-6736(18)31652-0","volume":"392","author":"P Willeit","year":"2018","unstructured":"Willeit P, Ridker PM, Nestel PJ, Simes J, Tonkin AM, Pedersen TR, et al. Baseline and on-statin treatment lipoprotein (a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials. Lancet. 2018;392(10155):1311\u201320.","journal-title":"Lancet"},{"issue":"5","key":"1204_CR69","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.jacc.2013.09.038","volume":"63","author":"PR Kamstrup","year":"2014","unstructured":"Kamstrup PR, Tybj\u00e6rg-Hansen A, Nordestgaard BG. Elevated lipoprotein (a) and risk of aortic valve stenosis in the general population. J Am Coll Cardiol. 2014;63(5):470\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"9298","key":"1204_CR70","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1016\/S0140-6736(01)07098-2","volume":"358","author":"G Walldius","year":"2001","unstructured":"Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein AI, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study. Lancet. 2001;358(9298):2026\u201333.","journal-title":"Lancet"},{"issue":"8","key":"1204_CR71","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.2337\/diacare.27.8.1991","volume":"27","author":"R Jiang","year":"2004","unstructured":"Jiang R, Schulze MB, Li T, Rifai N, Stampfer MJ, Rimm EB, et al. Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes. Diabetes Care. 2004;27(8):1991\u20137.","journal-title":"Diabetes Care"},{"issue":"11","key":"1204_CR72","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1001\/archinte.161.11.1413","volume":"161","author":"Y Cui","year":"2001","unstructured":"Cui Y, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P, Bachorik PS, et al. Non\u2013high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med. 2001;161(11):1413\u20139.","journal-title":"Arch Intern Med"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-020-01204-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12944-020-01204-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-020-01204-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T20:53:34Z","timestamp":1615841614000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-020-01204-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,16]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1204"],"URL":"https:\/\/doi.org\/10.1186\/s12944-020-01204-y","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,16]]},"assertion":[{"value":"5 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent was obtained from all subjects using protocols approved by the Ethics Committee of the Mashhad University of Medical Sciences.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}